drugset / Trial / NCT00346489

Outcomes of Intraoperative 5-Fluorouracil Versus Mitomycin C

NCT00346489

Phase 4 Completed 70 enrolled Indiana University
RandomizedParallel-groupDouble-blindTreatment

Summary

A clinical trial to establish the long term response of using intraoperative 5-fluorouracil (5-FU) versus mitomycin C (MMC) in trabeculectomy glaucoma surgery. Antiproliferative agents such as 5-fluorouracil and Mitomycin C have been used extensively in trabeculectomy surgery to improve the success of the surgery and prevent further visual loss and blindness in glaucoma patients.

Timeline

Start
2004-09
Primary completion
2007-08
Completion
2007-08

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Mitomycin C Other / unclassified
Subject fluorouracil Small molecule

Indications